Clinical trial
Pharmacokinetics of Emtricitabine/Tenofovir/Efavirenz in HIV-infected Patients…
NCT00474435 · African Poverty Related Infection Oriented Research Initiative, Other · Unknown status
Key facts
| NCT number | NCT00474435 |
|---|---|
| Title | Pharmacokinetics of Emtricitabine/Tenofovir/Efavirenz in HIV-infected Patients With Tuberculosis |
| Official title | The Pharmacokinetics of Co-formulated Emtricitabine/Tenofovir/Efavirenz in HIV-infected Patients With Smear-positive Pulmonary Tuberculosis in the Kilimanjaro Region, Tanzania |
| Acronym | PETE |
| Lead sponsor | African Poverty Related Infection Oriented Research Initiative, Other |
| Collaborators | Radboud University Medical Center Kilimanjaro Christian Medical Centre, Tanzania |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Tuberculosis, HIV Infections |
| Intervention type | Drug |
| Interventions | Emtricitabine/tenofovir/efavirenz |
| Enrollment | 30 |
| Start date | Nov 1, 2008 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | May 17, 2007 |
| Last update posted | Dec 17, 2010 |
| Countries | Tanzania |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: